Gaucher's Disease

14 registered clinical trials studyying Gaucher's Disease.

Status	Trial	Sponsor	Phase
Completed	Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type NCT04656600	Sanofi	Phase 4
Completed	A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or NCT06188325	Sanofi	Phase 1
Completed	A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth NCT06193304	Sanofi	Phase 1
Completed	Human Placental-Derived Stem Cell Transplantation NCT01586455	New York Medical College	Phase 1
Completed	Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease NCT01427517	University of Minnesota	Phase 1
Completed	Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Ste NCT00004294	National Center for Research Resources (NCRR)	Phase 1
Unknown	Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease NCT00004293	National Center for Research Resources (NCRR)	Phase 2
Unknown	Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoie NCT00005900	Fairview University Medical Center	—
Completed	Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease NCT00004488	Children's Hospital Medical Center, Cincinnati	Phase 2
Completed	Stem Cell Transplant for Inborn Errors of Metabolism NCT00176904	Masonic Cancer Center, University of Minnesota	Phase 2 / Phase 3
Completed	Bone Response to Enzyme Replacement in Gaucher's Disease NCT00001416	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 2
Completed	PEG-Glucocerebrosidase for the Treatment of Gaucher Disease NCT00001410	National Institute of Mental Health (NIMH)	Phase 1
Completed	Effects of Enzyme Replacement in Gaucher's Disease NCT00001289	National Institute of Neurological Disorders and Stroke (NINDS)	—
Completed	Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells NCT00001234	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 1